Elevated levels of proinflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP), have been observed in subsets of patients with depression and have been associated with poor treatment outcomes [4,5,6]. This evidence concerns the gene CRP and depressive symptom measurement.